138.23
1.03%
-1.44
Dopo l'orario di chiusura:
138.23
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CLX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$139.67
Aprire:
$139.5
Volume 24 ore:
2.01M
Capitalizzazione di mercato:
$17.17B
Reddito:
$7.31B
Utile/perdita netta:
$80.00M
Rapporto P/E:
203.28
EPS:
0.68
Flusso di cassa netto:
$728.00M
1 W Prestazione:
-5.63%
1M Prestazione:
-5.86%
6M Prestazione:
+10.10%
1 anno Prestazione:
-21.29%
Clorox Co. Stock (CLX) Company Profile
Nome
Clorox Co.
Settore
Industria
Telefono
510-271-7000
Indirizzo
1221 Broadway, Oakland, CA
Clorox Co. Stock (CLX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-02-05 | Downgrade | DA Davidson | Buy → Neutral |
2023-12-15 | Aggiornamento | BofA Securities | Underperform → Neutral |
2023-11-22 | Aggiornamento | JP Morgan | Underweight → Neutral |
2023-11-13 | Iniziato | Jefferies | Underperform |
2023-11-06 | Aggiornamento | UBS | Sell → Neutral |
2023-11-02 | Aggiornamento | Citigroup | Neutral → Buy |
2023-10-12 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
2023-10-05 | Downgrade | Raymond James | Outperform → Mkt Perform |
2023-10-02 | Aggiornamento | DA Davidson | Neutral → Buy |
2023-09-22 | Iniziato | HSBC Securities | Hold |
2023-08-03 | Aggiornamento | Atlantic Equities | Underweight → Neutral |
2023-02-17 | Iniziato | Citigroup | Neutral |
2022-10-18 | Iniziato | Evercore ISI | Underperform |
2022-10-17 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
2022-09-14 | Ripresa | BofA Securities | Underperform |
2022-07-13 | Iniziato | Raymond James | Outperform |
2022-02-04 | Downgrade | Atlantic Equities | Neutral → Underweight |
2022-02-04 | Reiterato | Deutsche Bank | Hold |
2022-02-04 | Reiterato | JP Morgan | Underweight |
2022-02-04 | Reiterato | Morgan Stanley | Underweight |
2022-02-04 | Reiterato | UBS | Sell |
2022-02-04 | Reiterato | Wells Fargo | Underweight |
2022-02-02 | Downgrade | Bernstein | Mkt Perform → Underperform |
2022-01-26 | Downgrade | Credit Suisse | Neutral → Underperform |
2021-11-02 | Reiterato | DA Davidson | Neutral |
2021-11-02 | Reiterato | Deutsche Bank | Hold |
2021-11-02 | Downgrade | JP Morgan | Neutral → Underweight |
2021-11-02 | Reiterato | Wells Fargo | Underweight |
2021-09-03 | Downgrade | Argus | Buy → Hold |
2021-08-04 | Downgrade | Atlantic Equities | Overweight → Neutral |
2021-08-04 | Reiterato | Citigroup | Buy |
2021-08-04 | Reiterato | Credit Suisse | Neutral |
2021-08-04 | Reiterato | Deutsche Bank | Hold |
2021-08-04 | Reiterato | Morgan Stanley | Underweight |
2021-08-04 | Reiterato | RBC Capital Mkts | Sector Perform |
2021-08-04 | Reiterato | UBS | Sell |
2021-08-04 | Reiterato | Wells Fargo | Underweight |
2021-06-24 | Iniziato | UBS | Sell |
2021-05-03 | Downgrade | Wells Fargo | Overweight → Underweight |
2021-03-18 | Downgrade | DA Davidson | Buy → Neutral |
2021-02-19 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
2021-01-20 | Iniziato | Bernstein | Mkt Perform |
2020-12-14 | Aggiornamento | Citigroup | Neutral → Buy |
2020-12-08 | Iniziato | Wells Fargo | Overweight |
2020-10-16 | Downgrade | JP Morgan | Overweight → Neutral |
2020-06-30 | Iniziato | DA Davidson | Buy |
2020-03-19 | Downgrade | Credit Suisse | Outperform → Neutral |
2020-03-16 | Aggiornamento | JP Morgan | Underweight → Overweight |
2020-03-09 | Aggiornamento | Argus | Hold → Buy |
2019-10-03 | Reiterato | BofA/Merrill | Neutral |
2019-09-23 | Downgrade | Barclays | Equal Weight → Underweight |
2019-05-20 | Downgrade | Argus | Buy → Hold |
2019-05-02 | Reiterato | BofA/Merrill | Neutral |
2019-05-02 | Aggiornamento | Deutsche Bank | Sell → Hold |
2019-04-08 | Downgrade | JP Morgan | Neutral → Underweight |
2019-03-07 | Iniziato | Credit Suisse | Outperform |
2018-12-06 | Reiterato | BofA/Merrill | Neutral |
2018-09-25 | Aggiornamento | Argus | Hold → Buy |
2018-07-18 | Downgrade | Goldman | Neutral → Sell |
2018-04-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2018-02-08 | Downgrade | Argus | Buy → Hold |
2018-01-04 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
Mostra tutto
Clorox Co. Borsa (CLX) Ultime notizie
Why Clorox (CLX) is a Top Growth Stock for the Long-Term
Zacks Investment Research
Why Clorox Stock Dropped on Wednesday
The Motley Fool
Clorox (CLX) Q3 Earnings Beat Estimates, Revenues Down Y/Y
Zacks Investment Research
Clorox (CLX) Reports Q3 Earnings: What Key Metrics Have to Say
Zacks Investment Research
Stocks Dive On Fears Of Hawkish Fed; Treasury Yields Rise, Bitcoin Tumbles To $60,000: What's Driving Markets Tuesday?
Benzinga
Wall Street On Edge Ahead Of Fed Decision, Spotlight Falls On Amazon And AMD Earnings: Analyst Says Stocks Survive 'Fragility Test' As April Ends
Benzinga
Clorox Co. Azioni (CLX) Dati Finanziari
Clorox Co. (CLX) Reddito 2024
CLX ha riportato un ricavo (TTM) di $7.31 miliardi per il trimestre terminato il 2023-12-31, un +3.47% salita anno su anno.
Clorox Co. (CLX) Reddito netto 2024
CLX l'utile netto (TTM) è stato di $80.00 milioni per il trimestre terminato il 2023-12-31, un -81.61% diminuire anno su anno.
Clorox Co. (CLX) Flusso di cassa 2024
CLX ha registrato un flusso di cassa disponibile (TTM) di $728.00 milioni per il trimestre conclusosi con 2023-12-31, un +0.97% aumento anno su anno.
Clorox Co. (CLX) Utile per azione 2024
L'utile per azione (TTM) di CLX è stato pari a $0.63 per il trimestre terminato il 2023-12-31, un -82.00% declino anno su anno.
Capitalizzazione:
|
Volume (24 ore):